nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—Pethidine—SLC6A3—attention deficit hyperactivity disorder	0.0486	0.572	CrCbGaD
Ketobemidone—Pethidine—SLC6A4—attention deficit hyperactivity disorder	0.0363	0.428	CrCbGaD
Ketobemidone—OPRD1—forebrain—attention deficit hyperactivity disorder	0.0329	0.0978	CbGeAlD
Ketobemidone—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0316	0.0938	CbGeAlD
Ketobemidone—OPRM1—forebrain—attention deficit hyperactivity disorder	0.0224	0.0667	CbGeAlD
Ketobemidone—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0179	0.0531	CbGeAlD
Ketobemidone—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.0172	0.0511	CbGeAlD
Ketobemidone—OPRK1—nervous system—attention deficit hyperactivity disorder	0.0171	0.0509	CbGeAlD
Ketobemidone—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.0165	0.049	CbGeAlD
Ketobemidone—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.0161	0.0479	CbGeAlD
Ketobemidone—OPRM1—midbrain—attention deficit hyperactivity disorder	0.0148	0.044	CbGeAlD
Ketobemidone—OPRD1—brain—attention deficit hyperactivity disorder	0.0137	0.0406	CbGeAlD
Ketobemidone—OPRK1—brain—attention deficit hyperactivity disorder	0.0131	0.0389	CbGeAlD
Ketobemidone—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0122	0.0362	CbGeAlD
Ketobemidone—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.0117	0.0349	CbGeAlD
Ketobemidone—PTGS1—forebrain—attention deficit hyperactivity disorder	0.0109	0.0325	CbGeAlD
Ketobemidone—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.0102	0.0304	CbGeAlD
Ketobemidone—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0101	0.0301	CbGeAlD
Ketobemidone—OPRM1—brain—attention deficit hyperactivity disorder	0.00931	0.0277	CbGeAlD
Ketobemidone—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.00926	0.0275	CbGeAlD
Ketobemidone—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00657	0.0195	CbGeAlD
Ketobemidone—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00633	0.0188	CbGeAlD
Ketobemidone—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00594	0.0177	CbGeAlD
Ketobemidone—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00572	0.017	CbGeAlD
Ketobemidone—CYP2C8—brain—attention deficit hyperactivity disorder	0.0056	0.0166	CbGeAlD
Ketobemidone—CYP2B6—brain—attention deficit hyperactivity disorder	0.00503	0.0149	CbGeAlD
Ketobemidone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00496	0.0148	CbGeAlD
Ketobemidone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00478	0.0142	CbGeAlD
Ketobemidone—PTGS1—brain—attention deficit hyperactivity disorder	0.00454	0.0135	CbGeAlD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00239	0.00414	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00239	0.00414	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00239	0.00414	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00236	0.00408	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00235	0.00407	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00232	0.00401	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00229	0.00396	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00228	0.00394	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00225	0.00389	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00225	0.00389	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00224	0.00388	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00224	0.00387	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00223	0.00385	CbGpPWpGaD
Ketobemidone—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00222	0.00385	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00222	0.00384	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00218	0.00376	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00214	0.00369	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00213	0.00368	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0021	0.00363	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00209	0.00361	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00208	0.0036	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00207	0.00358	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00206	0.00357	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00205	0.00354	CbGpPWpGaD
Ketobemidone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00203	0.00351	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00202	0.0035	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00201	0.00348	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00198	0.00342	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00196	0.00339	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00196	0.00339	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00196	0.00338	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00196	0.00338	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00193	0.00334	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00193	0.00333	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0019	0.00329	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0019	0.00328	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0019	0.00328	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00187	0.00323	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00183	0.00316	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00182	0.00315	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00182	0.00315	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00177	0.00306	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00177	0.00305	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00174	0.003	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00171	0.00296	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00171	0.00296	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0017	0.00294	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0017	0.00293	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00168	0.0029	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00166	0.00287	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00166	0.00287	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0016	0.00276	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00273	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00158	0.00272	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00156	0.0027	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00155	0.00269	CbGpPWpGaD
Ketobemidone—UGT1A9—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.00155	0.00268	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00155	0.00267	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00154	0.00266	CbGpPWpGaD
Ketobemidone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.00152	0.00263	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00149	0.00258	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00149	0.00258	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00147	0.00254	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00147	0.00254	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00145	0.00251	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00145	0.00251	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00145	0.0025	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00143	0.00248	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0014	0.00243	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00135	0.00233	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00134	0.00231	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00133	0.00231	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00133	0.0023	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00132	0.00229	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00132	0.00227	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00131	0.00227	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00128	0.00221	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00127	0.00219	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00126	0.00219	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00126	0.00218	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00124	0.00215	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00119	0.00206	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00118	0.00204	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00118	0.00203	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00117	0.00203	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00117	0.00202	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00115	0.00199	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00198	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.00198	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00114	0.00197	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00112	0.00194	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00112	0.00193	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00112	0.00193	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00192	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00111	0.00191	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0011	0.0019	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00109	0.00188	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00108	0.00186	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00107	0.00185	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00107	0.00185	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00107	0.00185	CbGpPWpGaD
Ketobemidone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00105	0.00181	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00104	0.00179	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00103	0.00179	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00103	0.00178	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00103	0.00178	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00176	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00101	0.00174	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.001	0.00173	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00173	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000998	0.00173	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000986	0.0017	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000982	0.0017	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000981	0.0017	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000973	0.00168	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000969	0.00168	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000963	0.00166	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000946	0.00163	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000937	0.00162	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000936	0.00162	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000935	0.00162	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000906	0.00157	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000903	0.00156	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000891	0.00154	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00088	0.00152	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000871	0.00151	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000851	0.00147	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000847	0.00146	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000844	0.00146	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000844	0.00146	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00083	0.00143	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000829	0.00143	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00082	0.00142	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000819	0.00142	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000814	0.00141	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000791	0.00137	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000776	0.00134	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000766	0.00132	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000763	0.00132	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000753	0.0013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000744	0.00129	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000721	0.00125	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000716	0.00124	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000715	0.00124	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000715	0.00124	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000711	0.00123	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000706	0.00122	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000703	0.00122	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000693	0.0012	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00068	0.00118	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000678	0.00117	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000655	0.00113	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000654	0.00113	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000644	0.00111	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000632	0.00109	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000631	0.00109	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000611	0.00106	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.0006	0.00104	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000595	0.00103	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000593	0.00102	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000583	0.00101	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000583	0.00101	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000575	0.000994	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000574	0.000992	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000573	0.000991	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000571	0.000988	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000553	0.000956	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000552	0.000955	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000545	0.000943	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000544	0.00094	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000535	0.000926	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000534	0.000924	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000533	0.000921	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000526	0.00091	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00052	0.000899	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000503	0.000869	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000487	0.000841	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000485	0.000839	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000484	0.000837	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000467	0.000808	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000466	0.000805	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000453	0.000782	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000445	0.000769	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000445	0.000769	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000445	0.000769	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000444	0.000767	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000443	0.000767	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000439	0.000759	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000437	0.000756	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000433	0.000749	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00043	0.000743	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000417	0.000721	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000409	0.000707	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000407	0.000703	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000387	0.000669	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000376	0.000651	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000376	0.000651	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00037	0.00064	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000355	0.000614	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000353	0.00061	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000351	0.000606	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000344	0.000595	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00034	0.000588	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000339	0.000586	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000338	0.000585	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000336	0.000581	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000336	0.000581	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000331	0.000571	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000307	0.000531	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000306	0.00053	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000306	0.00053	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000301	0.000521	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000301	0.00052	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000293	0.000506	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000287	0.000495	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000286	0.000495	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00028	0.000484	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000269	0.000466	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000269	0.000464	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000267	0.000462	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000256	0.000442	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000245	0.000423	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.000403	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000228	0.000394	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000226	0.000391	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00022	0.00038	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000205	0.000354	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000204	0.000352	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000202	0.000349	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000202	0.000349	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000202	0.000349	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000199	0.000344	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000196	0.000339	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	0.000186	0.000321	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000186	0.000321	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000185	0.000319	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000184	0.000319	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00018	0.000311	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000179	0.000309	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000162	0.000279	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.000266	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000152	0.000263	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000151	0.000262	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000122	0.000212	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000122	0.00021	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000116	0.0002	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	9.78e-05	0.000169	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	8.73e-05	0.000151	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	7.96e-05	0.000138	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	5.25e-05	9.07e-05	CbGpPWpGaD
